Back to results
US 2022/0281767 A1Published application
Bioactive crystallized glass ceramic comprising wollastonite, hydroxyapatite and diopside, and use thereof
AssigneeCg Bio Co., Ltd.
InventorsBaek-Hyun KIM, Hyun Seung RYU, Jun Hyuk SEO, Seok Beom SONG
Life of this patent
Estimating the term…
Abstract
The present invention relates to a glass ceramic composition comprising SiO2, Ca(OH)2, CaF2, B2O3, MgO, and hydroxyapatite; a bioactive crystallized glass ceramic comprising each of CaSiO3, Ca10(PO4)6(OH)2, and CaMgSi2O6 in an amount of 20% to 60% by weight; an implant for early osseointegration comprising the glass ceramic; and a method for manufacturing the implant.
Claims15
A glass ceramic composition comprising SiO2, Ca(OH)2, CaF2, B2O3, MgO, and hydroxyapatite.
A crystallized glass ceramic comprising CaSiO3, Ca10(PO4)6(OH)2, and CaMgSi2O6.
Dependencies are inferred from the claim text.